Skip to main content
. 2026 Jan 26;19(2):209. doi: 10.3390/ph19020209
SNR1 Serotonin–norepinephrine reuptake inhibitor
SSRI Selective serotonin reuptake inhibitors
ODV O-desmethylvenlafaxine
ADRs Adverse drug reactions
TDM Therapeutic drug monitoring
PGx Pharmacogenetic
AS Activity scores
MR Metabolic ratio
gPM Poor metabolizers
BMI Body mass index
gIM Intermediate metabolizer
gNM Normal metabolizer
gRM Rapid metabolizer
gUM Ultrarapid metabolizer
SNP Single nucleotide polymorphism
AGNP Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie
HPLC High-performance liquid chromatography